61 – 70 of 118
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Insulin-like growth factor-I, d3-GHR gene polymorphism, prematurity and height at start as determinants of one year growth response during high dose GH; preliminary results from the NESGA study (NESGAS)
(
- Contribution to journal › Published meeting abstract
-
Mark
Phenotypic characteristics of short children born SGA. Baseline data from the North European small for gestational age study (NESGAS)
(
- Contribution to journal › Published meeting abstract
-
Mark
Changes in body composition as assessed by DXA scan after one year of high dose growth hormone treatment in children born SGA. Results from the NESGAS group
(
- Contribution to journal › Published meeting abstract
-
Mark
Beneficial effects of growth hormone treatment in boys with Aarskog syndrome
(
- Contribution to journal › Published meeting abstract
-
Mark
Growth hormone (GH) dosing during catch-up growth guided by individual responsiveness decreases growth response variability in prepubertal children with GH deficiency or idiopathic short stature.
(
- Contribution to journal › Article
- 2008
-
Mark
Annual screening detects celiac disease in children with type 1 diabetes
(
- Contribution to journal › Article
-
Mark
A new luminescence assay for autoantibodies to mammalian cell-prepared insulinoma-associated protein 2
(
- Contribution to journal › Article
-
Mark
Selective screening of secretory vesicle-associated proteins for autoantigens in type 1 diabetes: VAMP2 and NPY are new minor autoantigens
(
- Contribution to journal › Article
-
Mark
Maternal enterovirus infection during pregnancy as a risk factor in offspring diagnosed with type 1 diabetes between 15 and 30 years of age.
(
- Contribution to journal › Article
-
Mark
Children developing type 1 diabetes before 6 years of age have increased linear growth independent of HLA genotypes.
(
- Contribution to journal › Article